Investor Alert: Kaplan Fox Investigates Nano-X Imaging For Potential Securities Fraud

NEW YORK, Sept. 18, 2020 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP ( is investigating claims on behalf of investors of Nano-X Imaging Ltd. ("Nano-X" or the "Company") (NASDAQ: NNOX).  A complaint has been filed on behalf of investors who purchased the publicly traded securities of Nano-X between August 21, 2020 and September 15, 2020, inclusive (the "Class Period").

According to the complaint, Nano-X's securities began trading on the NASDAQ on August 21, 2020.

On September 15, 2020, Citron Research ("Citron") published a report entitled "Nano-X Imaging (NNOX) A Complete Farce on the Market."  The Citron report described a series of red flags surrounding Nano-X, with Citron ultimately concluding that "this $3 billion company is nothing more than a science project with a simple rendering, minimal R&D, fake customers, no FDA approval, and fraudulent claims that are beyond the realm of possibility."   Nano-X subsequently issued a press release stating, among other things, that "[Nano-X] believes that the allegations in the report are completely without merit."

Following the publication of the Citron report, Nano-X's stock fell $11.21 per share, or nearly 23%, to close at $38.00 per share on September 15, 2020.   

If you are a member of the proposed Class, you may move the court no later than November 16, 2020 to serve as a lead plaintiff for the purported class.  You need not seek to become a lead plaintiff in order to share in any possible recovery.  If you would like to discuss the complaint or our investigation, please contact us by emailing or by calling 646-315-9003.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Kaplan Fox & Kilsheimer LLP, with offices in New York, San Francisco, Los Angeles, Chicago and New Jersey, has many years of experience in prosecuting investor class actions. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at  If you have any questions about this Notice, your rights, or your interests, please contact:

Donald R. Hall
850 Third Avenue, 14th Floor
New York, New York 10022
(646) 315-9003

Laurence D. King
1999 Harrison Street, Suite 1560
Oakland, California 94612
(415) 772-4704
Fax:  (415) 772-4707

Cision View original content:

SOURCE Kaplan Fox & Kilsheimer LLP

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.